Hugel Inc

Overview

Hugel Inc (Hugel) is a pharmaceutical company mainly engaged in the manufacturing of bio pharmaceuticals. The company's products include botulinum toxin, which is used for the treatment of benign essential blepharospasm and temporary improvement of moderate to severe glabellar lines including 50-unit types, 100 unit types and 200unit types, and hyaluronic acid for the temporary removal of facial wrinkles. It also provides cosmetics and medical devices such as wellage, a solution for rejuvenating skin; and blue rose used for facial tissue fixation.The company sells its products in domestic and overseas markets. Hugel is headquartered in Chuncheon, South Korea.
Key Stats
Address
61-20, Sinbuk-ro, Sinbuk-eup, Sinbuk eup, CHUNCHEON, South Korea
Headquarters

South Korea

Contact

82 33 8155200

Website
www.hugel.co.kr
No of Employees

126

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

145020 [KOSDAQ]

Revenue (2020)

$179 m

1.9% (2020 vs 2019)
Net Income (2020)

$36 m

-6% (2020 vs 2019)
Net Profit Margin

20 %

-8.8% (2020 vs 2019)
Market Cap *

$2,050 m

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Hugel IncBio-Rad Laboratories IncBioneer CorpCorestem Inc
Key Information
Headquarters South Korea United States of America South Korea South Korea
Headquarter City CHUNCHEON HERCULES DAEJEON SEOUL
Headquarter State/Province - California - -
No. of Employees 126 8,000 281 40
Entity Type Public Public Public Public

Products & Services

Hugel operates as a pharmaceutical company. The key products offered by the company include the following:

Products
  • Botulinum toxin
  • Hyaluronic acid filler
  • Cosmetics
  • Vitae Eget Libero
  • Vitae Eget Libero
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Stake Sale In August, the company sold 46.9% stake held by Bain Capital to consortium of investors…
2018 Contracts/Agreements In September, Hugel along with Croma-Pharma announced plans to establish a new joint venture company…

Locations


Across Co Ltd

Address

Seolleung-ro, Gangnam-gu, seoul
South Korea

Telephone

82 2 69661800

Website

www.revolax.com
J World Co.,Ltd.

Address

905, Hansol Technotown, 16-1, Danjung-Dong, Gyeonggi-Do, Gunpo
South Korea

Telephone

82 - 314568001

Website

www.jworld21.com

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
27 Aug 2021 Bain Capital to Sell its Stake in Hugel Private Equity Hugel Inc
18 Jun 2021 Shinsegae Plans to Acquire Hugel Acquisition Shinsegae Inc Hugel Inc
08 Jul 2019 LG Household & Health Care to Acquire Hugel Acquisition LG Household & Health Care Ltd Hugel Inc
05 Sep 2018 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
15 Nov 2017 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
14 Jul 2017 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit